Endoscope public health advisory
This article was originally published in The Gray Sheet
Executive Summary
Inconsistencies between reprocessing instructions provided by an automated endoscope reprocessessor (AER) manufacturer and the maker of a reusable bronchoscope device apparently led to several incidents in which patients developed serious infections after undergoing a bronchoscope examination, FDA and the Centers for Disease Control and Prevention state in a Sept. 10 public health advisory. In addition, "bronchoscopes were inadequately reprocessed when inappropriate channel connectors were used with the AER," according to the statement